Sign in
4

Changes in Ownership

REGENERON PHARMACEUTICALS, INC. Filed Acc 0001968202-24-000119

EVP Research sold 6,363 shares at an average $1,153.15 ($7,337,505)

  • EVP Research gave up 13,637 shares (to pay taxes)
  • EVP Research acquired 20,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

MURPHY ANDREW J · EVP Research

Table I: Non-derivative

20 lines
Date Transaction Shares Price Value Owned after D/I
2024-08-13 Exercise or conversion : show line 1 in the form 10b5-1 +20,000 $399.66 $7,993,200 68,306 D
2024-08-13 Shares withheld for taxes : show line 2 in the form 10b5-1 −13,637 $1,141.49 $15,566,499 54,669 D
2024-08-14 Sale : show line 3 in the form 10b5-1 −55 $1,140.31 $62,717 54,614 D
2024-08-14 Sale : show line 4 in the form 10b5-1 −48 $1,142.94 $54,861 54,566 D
2024-08-14 Sale : show line 5 in the form 10b5-1 −79 $1,143.28 $90,319 54,487 D
2024-08-14 Sale : show line 6 in the form 10b5-1 −45 $1,144.89 $51,520 54,442 D
2024-08-14 Sale : show line 7 in the form 10b5-1 −148 $1,145.58 $169,546 54,294 D
2024-08-14 Sale : show line 8 in the form 10b5-1 −51 $1,146.60 $58,477 54,243 D
Open-market sales · 6,363 sh · avg $1,153.15 · $7,337,505

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-08-13 Exercise or conversion : show line 21 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −20,000 0 D
Loading xslF345X05/edgardoc.xml…